Ex Parte CHANDRA et al - Page 4



          Appeal No. 2003-1873                                                        
          Application 09/281,420                                                      

                                       OPINION                                        

               With full consideration being given to the subject matter on           
          appeal, the Examiner’s rejections and the arguments of the                  
          Appellants and the Examiner, for the reasons stated infra, we               
          affirm the Examiner’s rejection of claims 1-2, 8, 10, 19-21,                
          24-28, 34, 36, 45-47, 50 and 52 under 35 U.S.C. § 103 and we                
          reverse the Examiner’s rejection of claims 3, 6-7, 11-15, 17-18,            
          29, 32-33, 37-41, 43-44, and 51 under 35 U.S.C. § 103.                      

               Appellants have indicated that for purposes of this appeal             
          the claims stand or fall together in three groupings:                       
                    Claims 1-2, 8, 10, 24-25, 27-28, 34, 36 and 50 as                 
                    Group I;                                                          
                    Claims 3, 6-7, 11-15, 17-18, 29, 32-33, 37-41, 43-44,             
                    and 51 as Group II; and                                           
                    Claims 19-21, 26, 45-47 and 52 as Group III.                      

          See page 6 of the brief.  Furthermore, Appellants argue each                
          group of claims separately and explain why the claims of each               
          group are believed to be separately patentable.  See pages 6-13             
          of the brief and pages 2-4 of the reply brief.  Appellants have             
          fully met the requirements of 37 CFR § 1.192 (c)(7) (July 1,                
                                          4                                           



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007